Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245005 · ClinicalTrials.gov registry record
Preoperative Cognitive Reserve in Older Surgical Patients: A Feasibility Study
A clinical trial of Cognitive Decline, sponsored by Ohio State University.
- Completed
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06245005: Completed study of Cognitive Decline, sponsored by Ohio State University.
NCT06245005 is a study of Cognitive Decline that has completed, run by Ohio State University. The registered enrollment target is 120 participants, below the 1,147-participant average among 61 other Cognitive Decline trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245005, a study of Cognitive Decline, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will evaluate feasibility of using a custom 6-game Lumosity brain exercise experience in busy clinical areas to obtain a quick, quantitative measure of cognitive reserve (first gameplay performance \[FGP\]) in older patients presenting for major surgery. Participants in this feasibility trial will serve as a pilot population to estimate postoperative delirium incidence in patients willing and able to complete the brief, self-directed, brain exercise experience on a portable electronic device in various preoperative encounters, and will provide insight into which preoperative encounter (outpatient clinic or morning of surgery preoperative holding) may be more conducive to brief preoperative cognitive evaluations and interventions in future studies. First gameplay performance obtained during study procedures will be compared based upon postoperative delirium status (positive verse negative) to evaluate predictive value of the custom 6-game battery. This will guide future studies of FGP as a quick, quantitative measure of cognitive reserve in older surgical patients, with potentially more utility in preoperative patients than other assessments of cognitive function.
Primary Outcome
Determine if brain exercise gameplay on a portable electronic device is feasible in two different preoperative settings (The Ohio State Preoperative Assessment Clinic (OPAC) and The Wexner Medical Center Preoperative Holding Areas).
Conditions Studied
Interventions
- DEVICE Brain exercise gameplay on a portable electronic device
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2026-01-30 |
What the finished NCT06245005 record still lists
NCT06245005 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,147-participant average among 61 other Cognitive Decline trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Brain exercise gameplay on a portable electronic device is the first listed.
NCT06245005 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06245005 about?
NCT06245005 is a clinical study titled "Preoperative Cognitive Reserve in Older Surgical Patients: A Feasibility Study". Investigators will evaluate feasibility of using a custom 6-game Lumosity brain exercise experience in busy clinical areas to obtain a quick, quantitative measure of cognitive reserve (first gameplay performance \[FGP\]) in older patients presenting for major surgery. Participants in this feasibilit...
What is the current status of trial NCT06245005?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2023-09-20. Estimated completion is 2026-01-30.
What conditions does trial NCT06245005 study?
This clinical trial studies the following conditions: Cognitive Decline.
What interventions are being tested in trial NCT06245005?
The interventions under investigation include: Brain exercise gameplay on a portable electronic device (DEVICE).
Who is sponsoring clinical trial NCT06245005?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06245005 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06245005's enrollment target sits among peer trials
120 37th of 61 higher than 24 of 61 other Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Older Breast Cancer Patients: Risk for Cognitive Decline
RECRUITING
-
Biomarker Exploration in Aging, Cognition and Neurodegeneration
RECRUITING · Phase 3
-
Glucose Variability and Cognition in Prediabetes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI